Monsanto Company is wholly owned by the German multinational pharmaceutical and life sciences enterprise Bayer AG. Bayer finalized a massive $63 billion cash acquisition of the U.S. agricultural giant in June 2018. Following the transaction, Monsanto ceased to operate as an independent publicly traded entity. Its shares were delisted from the New York Stock Exchange, and the iconic corporate name was largely phased out of public-facing branding in favor of Bayer's unified corporate identity.
Understanding who owns Monsanto requires looking past a simple corporate directory. The purchase transferred not just physical assets and seed patents, but a staggering wave of historical legal liabilities that continue to impact Bayer's market valuation today. This deep dive unpacks the corporate structure behind the buyout, the motives of the merger, and the ongoing fallout of absorbing one of the world's most controversial agrochemical names.
The 2018 Bayer Takeover: Deal Mechanics
The journey toward the 2018 merger began years prior as consolidation reshaped the global agricultural chemical sector. Competitors like Dow Chemical and DuPont merged, while ChemChina acquired Syngenta. To maintain a competitive edge in seeds and crop protection, Bayer pursued Monsanto aggressively.
Bayer offered $128 per share in cash, valuing the total enterprise value at roughly $66 billion. Regulators across the United States, European Union, and other jurisdictions subjected the deal to intense antitrust scrutiny. To win regulatory clearance, Bayer was forced to divest several major portions of its own seed and herbicide businesses—selling them to rival BASF for nearly $9 billion.
When the transaction closed on June 7, 2018, Monsanto was absorbed entirely into Bayer's Crop Science division. While internal legal entities sometimes retain legacy names for administrative continuity, Monsanto no longer exists as a standalone corporation with public shareholders. It functions entirely as a subsidiary asset managed from Leverkusen, Germany.
Phasing Out the Monsanto Brand
Almost immediately after the purchase closed, Bayer made a strategic decision to drop the Monsanto name from its corporate lexicon. Consumer trust in the brand had been deeply eroded over decades of environmental and health controversies involving products like Roundup (glyphosate), Agent Orange, and polychlorinated biphenyls (PCBs).
Bayer retained the underlying science, seed genetics, and crop protection portfolios, but rebranded them under the Bayer corporate umbrella. Seeds previously sold under Monsanto-affiliated labels were integrated into Bayer's global agricultural offerings. Company leadership argued that the rebrand was necessary to align the acquired assets with Bayer's core life-sciences mission, though critics viewed it as an attempt to shed toxic public relations baggage.
The Financial and Legal Aftermath
The acquisition is widely studied in business schools as a cautionary tale of poor due diligence regarding mass tort liability. At the time of the buyout, thousands of lawsuits were already mounting against Monsanto regarding the alleged cancer-causing risks of its glyphosate-based weedkillers.
Within years of the purchase, Bayer faced tens of thousands of additional U.S. claims. The parent company has since spent over $10 billion in settlements and set aside provisions exceeding $16 billion total to resolve ongoing litigation relating to glyphosate, PCBs, and dicamba. These legal battles depressed Bayer's stock price significantly, wiping out billions in market value for Bayer shareholders who initially approved the transaction.
According to financial filings from the U.S. Securities and Exchange Commission, Bayer continues to restructure its legal defense strategy, attempting to push federal preemption arguments through the court system while settling state-level environmental claims.
Frequently Asked Questions
Does Monsanto still exist as a company?
No. Monsanto ceased to exist as an independent legal and publicly traded entity when Bayer completed its acquisition in 2018. Its operations, assets, and intellectual property were folded directly into Bayer's Crop Science division.
Why did Bayer buy Monsanto despite the legal risks?
Bayer sought to dominate the global market for seeds and agricultural biotechnology. Management believed that combining Bayer's pharmaceutical and chemical expertise with Monsanto's proprietary seed traits would create an unbeatable agricultural powerhouse. However, analysts agree that Bayer severely underestimated the scope of legacy litigation.
Who owns the Roundup brand now?
Roundup is owned and manufactured by Bayer. While the physical product and its chemical formula remain on the market for agricultural and residential use in various formulations, Bayer has actively worked to phase out glyphosate for residential lawn use to curb future legal exposure.
What other companies were involved in the 2018 agrochemical consolidation?
The Bayer-Monsanto merger occurred amid a massive wave of industry consolidation. Around the same time, Dow Chemical merged with DuPont to form DowDuPont (later splitting into separate entities), and state-owned ChemChina acquired Swiss agrochemical pioneer Syngenta.
Can consumers still buy Monsanto-branded products?
You won't find products bearing the Monsanto name on store shelves. Bayer retired the brand name post-acquisition to distance its consumer-facing lines from historical controversies, replacing it with the corporate Bayer badge.
